ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1948

Decreased C4A Gene Copy Numbers in Children with Juvenile Dermatomyositis: Association with Decreased C4 Protein and Lower Absolute Number of CD3 Negative CD16/56+ Natural Killer Cells

Lauren M. Pachman1, Katherine E. Lintner2, Yee Ling Wu2, Lori J. Ferguson3, Gabrielle A. Morgan4, Chiang-Ching Huang5 and C. Yung Yu6, 1Division of Pediatric Rheumatology, Northwestern University Feinberg School of Medicine, Chicago, IL, 2The Research Institute at Nationwide Children's Hospital and The Ohio State University, Columbus, OH, 3Children's Hospital of Chicago Research Center, Cure JM Myositis Center, Chicago, IL, 4Cure JM Myositis Center, Ann & Robert H. Lurie Children's Hospital of Chicago Research Center, Chicago, IL, 5Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, 6Center for Molecular and Human Genetics, The Research Institute at Nationwide Children's Hospital and The Ohio State University, Columbus, OH

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Juvenile dermatomyositis and natural killer (NK) cells

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Muscle Biology, Myositis and Myopathies: Genetics, Autoantibodies and other Molecular Aspects of Idiopathic Inflammatory Myopathies and Models

Session Type: Abstract Submissions (ACR)

Background/Purpose: Juvenile Dermatomyositis (JDM), a systemic vasculopathy, is member of the family of autoimmune diseases. In 56% of untreated JDM, a decrease in the absolute number of natural killer cells reflects immune activation and increased disease activity. JDM is also associated with B*08, DRB1*03, DQA1*0501, C4B1, C4AQ0 (null), and TNFA-308A polymorphism, in linkage disequilibrium on chromosome 6.  In the families of children with JDM, there is a significant increase in the history of systemic lupus erythematosus (SLE). Patients with SLE, have an overrepresentation of C4A null alleles, with associated decreased levels of the C4 protein. The frequency of C4A deficiency in children with JDM is unknown. Objective:To determine the association of C4 protein and other clinical parameters with C4A gene copy number in JDM.

Methods: A cross-sectional cohort of children, n=91, with definite/probable JDM (overlap syndromes excluded) were enrolled (IRB# 2008-13457).  There were 78% (71/91) girls, 96.7% (88/91) White, mean age of 5.06 yrs, and 35% (32/91) were untreated at time of first visit.  Genomic DNA was assessed for gene copy number (GCN) for total C4, C4A and C4Bby real time qPCR; EDTA-plasma was used to determine C4A and C4B polymorphisms and validate genotype data.  Data for C4 protein concentrations, disease activity scores (DAS) for skin involvement and muscle weakness were obtained, along with nailfold capillary end row loop number, and absolute cell count of CD3negative, CD56/16 positive natural killer (NK) cells at time of first visit.  NHANES normative data obtained from 523 subjects for C4A gene copy number were used as a comparator.

Results: Patients with JDM have lower C4A GCN than the general population (30% vs. 17% with 0-1 copy, p=0.009, Chi-square test). The level of C4 protein was significantly associated with the C4 total gene copy number, p<0.001; the C4 protein levels increases by 3.61 unit/one C4 copy number. The C4 protein concentration was not significantly associated with any of the following: nailfold capillary end row loop number, DAS skin or DAS muscle.  However, there was a significant association of the C4AGCN with the absolute number of circulating CD3negative NK cells in JDM (p=0.02).

Conclusion: Children with JDM have decreased levels of C4 protein as a function of significantly decreased GCN of C4. Although the decreased C4 was not associated with nailfold capillary end row loop numbers, or clinical disease activity markers, the C4A GCN appeared to be associated with the absolute levels of circulating NK cells, suggesting a locus of control on chromosome 6.  We speculate that the decrease in C4 as a consequence of C4A GCN may contribute to the pathogenetic mechanisms of damage in JDM.


Disclosure:

L. M. Pachman,

NIH- R0-1 ; Education grant from Behring for $5,000,

2;

K. E. Lintner,
None;

Y. L. Wu,
None;

L. J. Ferguson,
None;

G. A. Morgan,
None;

C. C. Huang,
None;

C. Y. Yu,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/decreased-c4a-gene-copy-numbers-in-children-with-juvenile-dermatomyositis-association-with-decreased-c4-protein-and-lower-absolute-number-of-cd3-negative-cd1656-natural-killer-cells/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology